New horizons in the pathogenesis, assessment and management of delirium

Alasdair M J Maclullich, Atul Anand, Daniel H J Davis, Thomas Jackson, Amanda J Barugh, Roanna J Hall, Karen J Ferguson, David J Meagher, Colm Cunningham, Alasdair M J Maclullich, Atul Anand, Daniel H J Davis, Thomas Jackson, Amanda J Barugh, Roanna J Hall, Karen J Ferguson, David J Meagher, Colm Cunningham

Abstract

Delirium is one of the foremost unmet medical needs in healthcare. It affects one in eight hospitalised patients and is associated with multiple adverse outcomes including increased length of stay, new institutionalisation, and considerable patient distress. Recent studies also show that delirium strongly predicts future new-onset dementia, as well as accelerating existing dementia. The importance of delirium is now increasingly being recognised, with a growing research base, new professional international organisations, increased interest from policymakers, and greater prominence of delirium in educational and audit programmes. Nevertheless, the field faces several complex research and clinical challenges. In this article we focus on selected areas of recent progress and/or uncertainty in delirium research and practice. (i)

Pathogenesis: recent studies in animal models using peripheral inflammatory stimuli have begun to suggest mechanisms underlying the delirium syndrome as well as its link with dementia. A growing body of blood and cerebrospinal fluid studies in humans have implicated inflammatory and stress mediators. (ii)

Prevention: delirium prevention is effective in the context of research studies, but there are several unresolved issues, including what components should be included, the role of prophylactic drugs, and the overlap with general best care for hospitalised older people. (iii)

Assessment: though there are several instruments for delirium screening and assessment, detection rates remain dismal. There are no clear solutions but routine screening embedded into clinical practice, and the development of new rapid screening instruments, offer potential. (iv)

Management: studies are difficult given the heterogeneity of delirium and currently expert and comprehensive clinical care remains the main recommendation. Future studies may address the role of drugs for specific elements of delirium. In summary, though facing many challenges, the field continues to make progress, with several promising lines of enquiry and an expanding base of interest among researchers, clinicians and policymakers.

Keywords: delirium; delirium assessment; delirium management; delirium pathogenesis; older people.

References

    1. Lindesay J, Rockwood K, Macdonald A. Delirium in old age. Oxford, New York: Oxford University Press; 2002.
    1. NCG Centre. Delirium: Diagnosis, Prevention and Management. 2010.
    1. Young J, Hood C, Gandesha A, Souza R. National Audit of Dementia Care in General Hospitals 2012–2013: Second Round Audit Report and Update. London: HQIP; 2013.
    1. Davis DH, Muniz Terrera G, Keage H, et al. Delirium is a strong risk factor for dementia in the oldest-old: a population-based cohort study. Brain. 2012;135(Pt 9):2809–16.
    1. Fong TG, Jones RN, Shi P, Marcantonio ER, Yap L, Rudolph JL, et al. Delirium accelerates cognitive decline in Alzheimer disease. Neurology. 2009;72:1570–5.
    1. Maclullich AM, Ferguson KJ, Miller T, de Rooij SE, Cunningham C. Unravelling the pathophysiology of delirium: a focus on the role of aberrant stress responses. J Psychosom Res. 2008;65:229–38.
    1. Khan BA, Zawahiri M, Campbell NL, Boustani MA. Biomarkers for delirium–a review. J Am Geriatr Soc. 2011;59(Suppl. 2):S256–61.
    1. Cunningham C, Maclullich AM. At the extreme end of the psychoneuroimmunological spectrum: delirium as a maladaptive sickness behaviour response. Brain Behav Immun. 2013;28:1–13.
    1. Hall RJ, Shenkin SD, Maclullich AM. A systematic literature review of cerebrospinal fluid biomarkers in delirium. Dement Geriatr Cogn Disord. 2011;32:79–93.
    1. de Rooij SE, Van Munster BC, Korevaar JC, Levi M. Cytokines and acute phase response in delirium. J Psychosom Res. 2007;62:521–5.
    1. van Munster BC, Korevaar JC, Zwinderman AH, Levi M, Wiersinga WJ, De Rooij SE. Time-course of cytokines during delirium in elderly patients with hip fractures. J Am Geriatr Soc. 2008;56:1704–9.
    1. Adamis D, Lunn M, Martin FC, et al. Cytokines and IGF-1 in delirious and non-delirious acutely ill older medical patients. Age and Ageing. 2009;38:326–32.
    1. Wilson K, Broadhurst C, Driver M, Jackson M, Mottram P. Plasma insulin growth factor-1 and incident delirium in older people. Int J Geriatr Psychiatry. 2005;20:154–9.
    1. MacLullich AM, Edelshain BT, Hall RJ, et al. Cerebrospinal fluid interleukin-8 levels are higher in people with hip fracture with perioperative delirium than in controls. J Am Geriatr Soc. 2011;59:1151–3.
    1. Bisschop PH, de Rooij SE, Zwinderman AH, van Oosten HE, van Munster BC. Cortisol, insulin and glucose and the risk of delirium in older adults with hip fracture. J Am Geriatr Soc. 2011;59:1692–6.
    1. Pearson A, de Vries A, Middleton S, et al. Cerebrospinal fluid cortisol levels are higher in patients with delirium versus controls. BMC Res Notes. 2010;3:33.
    1. Ramirez-Bermudez J, Ruiz-Chow A, Perez-Neri I, et al. Cerebrospinal fluid homovanillic acid is correlated to psychotic features in neurological patients with delirium. Gen Hospital Psychiatry. 2008;30:337–43.
    1. Cunningham C, Campion S, Lunnon K, et al. Systemic Inflammation Induces Acute Behavioral and Cognitive Changes and Accelerates Neurodegenerative Disease. Biol Psychiatry. 2009;65:304–12.
    1. Hall RJ, Ferguson KJ, Andrews M, et al. Delirium and cerebrospinal fluid S100B in hip fracture patients: a preliminary study. Am J Geriatr Psychiatry. 2013 [Epub ahead of print]
    1. van Munster BC, Korevaar JC, Korse CM, Bonfrer JM, Zwinderman AH, de Rooij SE. Serum S100B in elderly patients with and without delirium. Int J Geriatr Psychiatry. 2010;25:234–9.
    1. Leavitt ML, Trzepacz PT, Ciongoli K. Rat model of delirium: atropine dose-response relationships. J Neuropsychiatry Clin Neurosci. 1994;6:279–84.
    1. Semmler A, Hermann S, Mormann F, et al. Sepsis causes neuroinflammation and concomitant decrease of cerebral metabolism. J Neuroinflammation. 2008;5:38.
    1. Sanders RD, Godlee A, Fujimori T, et al. Benzodiazepine augmented gamma-amino-butyric acid signaling increases mortality from pneumonia in mice*. Crit Care Med. 2013;41:1627–36.
    1. Belotti M, Cagniard B, Mano MP, Galey D. Modulation of spatial alternation and anxiety by septal scopolamine systemic diazepam in mice. Pharmacol Biochem Behav. 1998;60:733–8.
    1. Imamura Y, Wang H, Matsumoto N, et al. Interleukin-1beta causes long-term potentiation deficiency in a mouse model of septic encephalopathy. Neuroscience. 2011;187:63–9.
    1. Cibelli M, Fidalgo AR, Terrando N, et al. Role of interleukin-1beta in postoperative cognitive dysfunction. Ann Neurol. 2010;68:360–8.
    1. Serantes R, Arnalich F, Figueroa M, et al. Interleukin-1beta enhances GABAA receptor cell-surface expression by a phosphatidylinositol 3-kinase/Akt pathway: relevance to sepsis-associated encephalopathy. J Biol Chem. 2006;281:14632–43.
    1. Chen J, Buchanan JB, Sparkman NL, Godbout JP, Freund GG, Johnson RW. Neuroinflammation and disruption in working memory in aged mice after acute stimulation of the peripheral innate immune system. Brain Behav Immun. 2008;22:301–11.
    1. Murray C, Sanderson DJ, Barkus C, et al. Systemic inflammation induces acute working memory deficits in the primed brain: relevance for delirium. Neurobiol Aging. 2012;33:603–16. e3.
    1. Cunningham C, Wilcockson DC, Campion S, Lunnon K, Perry VH. Central and systemic endotoxin challenges exacerbate the local inflammatory response and increase neuronal death during chronic neurodegeneration. J Neurosci. 2005;25:9275–84.
    1. Griffin EW, Skelly DT, Murray CL, Cunningham C. Cyclooxygenase-1 dependent prostaglandins mediate susceptibility to systemic inflammation-induced acute cognitive dysfunction. J Neurosci. 2013 in press )
    1. Field RH, Gossen A, Cunningham C. Prior pathology in the basal forebrain cholinergic system predisposes to inflammation induced working memory deficits: reconciling inflammatory and cholinergic hypotheses of delirium. J Neurosci. 2012;32:6288–94.
    1. van den Boogaard M, Pickkers P, Slooter AJ, et al. Development and validation of PRE-DELIRIC (PREdiction of DELIRium in ICu patients) delirium prediction model for intensive care patients: observational multicentre study. BMJ. 2012;344:e420.
    1. Rudolph JL, Jones RN, Levkoff SE, et al. Derivation and validation of a preoperative prediction rule for delirium after cardiac surgery. Circulation. 2009;119:229–36.
    1. Pol RA, van Leeuwen BL, Visser L, et al. Standardised frailty indicator as predictor for postoperative delirium after vascular surgery: a prospective cohort study. Eur J Vasc Endovasc Surg. 2011;42:824–30.
    1. Inouye SK, Bogardus ST, Charpentier PA, et al. A multicomponent intervention to prevent delirium in hospitalized older patients. N Engl J Med. 1999;340:669–76.
    1. Marcantonio ER, Flacker JM, Wright RJ, Resnick NM. Reducing delirium after hip fracture: a randomized trial. J Am Geriatr Soc. 2001;49:516–22.
    1. Lundstrom M, Edlund A, Karlsson S, Brannstrom B, Bucht G, Gustafson Y. A multifactorial intervention program reduces the duration of delirium, length of hospitalization, and mortality in delirious patients. J Am Geriatr Soc. 2005;53:622–8.
    1. Siddiqi N, Young J, House AO, et al. Stop Delirium! A complex intervention to prevent delirium in care homes: a mixed-methods feasibility study. Age Ageing. 2011;40:90–8.
    1. Morandi A, Brummel NE, Ely EW. Sedation, delirium and mechanical ventilation: the ‘ABCDE’ approach. Curr Opin Critical Care. 2011;17:43–9.
    1. Akunne A, Murthy L, Young J. Cost-effectiveness of multi-component interventions to prevent delirium in older people admitted to medical wards. Age Ageing. 2012;41:285–91.
    1. Meagher D, McLoughlin L, Leonard M, Hannon N, Dunne C. What do we really know about the treatment of delirium with antipsychotics? Ten key issues for delirium pharmacotherapy. Am J Geriatr Psychiatry. 2012 in press)
    1. Hempenius L, van Leeuwen BL, van Asselt DZ, et al. Structured analyses of interventions to prevent delirium. Int J Geriatr Psychiatry. 2011;26:441–50.
    1. Meagher DJ. Impact of an educational workshop upon attitudes towards pharmacotherapy for delirium. Int Psychogeriatr. 2010;22:938–46.
    1. Collins N, Blanchard MR, Tookman A, Sampson EL. Detection of delirium in the acute hospital. Age Ageing. 2010;39:131–5.
    1. Ryan DJ, O'Regan NA, Caoimh RO, et al. Delirium in an adult acute hospital population: predictors, prevalence and detection. BMJ Open. 2013;3:0.
    1. Hall RJ, Meagher DJ, Maclullich AM. Delirium detection and monitoring outside the ICU. Best Pract Res Clin Anaesthesiol. 2012;26:367–83.
    1. Physicians. RCo. Standardising the Assessment of Acute Illness Severity in the NHS. London: RCP; 2012.
    1. Tieges Z, McGrath A, Hall RJ, MacLullich AMJ. Abnormal level of arousal as a predictor of delirium and inattention: an exploratory study. Am J Geriatr Psychiatry. 2013 in press)
    1. Chester JG, Beth Harrington M, Rudolph JL. Serial administration of a modified Richmond agitation and sedation scale for delirium screening. J Hosp Med. 2012;7:450–3.
    1. O'Hanlon S, O'Regan N, Maclullich AM, et al. Improving delirium care through early intervention: from bench to bedside to boardroom. J Neurol Neurosurg Psychiatry. 2013 [Epub ahead of print]
    1. Inouye SK, van Dyck CH, Alessi CA, Balkin S, Siegal AP, Horwitz RI. Clarifying confusion: the confusion assessment method. A new method for detection of delirium. Ann Intern Med. 1990;113:941–8.
    1. Han JH, Wilson A, Vasilevskis EE, et al. Diagnosing delirium in older emergency department patients: validity and reliability of the delirium triage screen and the brief confusion assessment method. Ann Emerg Med. 2013 [Epub ahead of print]
    1. Gaudreau JD, Gagnon P, Harel F, Tremblay A, Roy MA. Fast, systematic, and continuous delirium assessment in hospitalized patients: the nursing delirium screening scale. J Pain Symptom Manage. 2005;29:368–75.
    1. Schuurmans MJ, Shortridge-Baggett LM, Duursma SA. The Delirium Observation Screening Scale: a screening instrument for delirium. Res Theory Nurs Pract. 2003;17:31–50. Spring.
    1. Morandi A, McCurley J, Vasilevskis EE, et al. Tools to detect delirium superimposed on dementia: a systematic review. J Am Geriatr Soc. 2012;60:2005–13.
    1. Breitbart W, Rosenfeld B, Roth A, Smith MJ, Cohen K, Passik S. The memorial delirium assessment scale. J Pain Symp Manage. 1997;13:128–37.
    1. Trzepacz PT, Mittal D, Torres R, Kanary K, Norton J, Jimerson N. Validation of the Delirium Rating Scale-revised-98: Comparison with the Delirium Rating Scale and the Cognitive Test for Delirium. J Neuropsychiatry Clin Neurosci. 2001;13:229–42.
    1. Hart RP, Levenson JL, Sessler CN, Best AM, Schwartz SM, Rutherford LE. Validation of a cognitive test for delirium in medical ICU patients. Psychosomatics. 1996;37:533–46.
    1. Brown LJ, Ferner HS, Robertson J, et al. Differential effects of delirium on fluid and crystallized cognitive abilities. Arch Gerontol Geriatr. 2011;52:153–8.
    1. Thomas C, Hestermann U, Kopitz J, Plaschke K, Oster P, Driessen M, et al. Serum anticholinergic activity and cerebral cholinergic dysfunction: an EEG study in frail elderly with and without delirium. BMC Neurosci. 2008;9:86.
    1. Ferguson KJ, MacLullich AMJ. Neuroimaging of delirium. In: Stevens RD, Sharshar T, Ely EW, editors. Brain Disorders in Critical Illness. Cambridge: Cambridge University Press; 2013.
    1. Lai MM, Wong Tin Niam DM. Intracranial cause of delirium: computed tomography yield and predictive factors. Intern Med J. 2012;42:422–7.
    1. Goldberg SE, Bradshaw LE, Kearney FC, et al. Care in specialist medical and mental health unit compared with standard care for older people with cognitive impairment admitted to general hospital: randomised controlled trial (NIHR TEAM trial) BMJ. 2013;347:f4132.
    1. Morandi A, Davis D, Taylor JK, et al. Consensus and variations in opinions on delirium care: a survey of European delirium specialists. Int Psychogeriatr. 2013:1–9. [Epub ahead of print]
    1. Tahir TA, Eeles E, Karapareddy V, et al. A randomized controlled trial of quetiapine versus placebo in the treatment of delirium. J Psychosom Res. 2010;69:485–90.
    1. Devlin JW, Roberts RJ, Fong JJ, et al. Efficacy and safety of quetiapine in critically ill patients with delirium: a prospective, multicenter, randomized, double-blind, placebo-controlled pilot study. Crit Care Med. 2010;38:419–27.
    1. Campbell N, Boustani MA, Ayub A, et al. Pharmacological management of delirium in hospitalized adults–a systematic evidence review. J Gen Intern Med. 2009;24:848–53.
    1. Hakim SM, Othman AI, Naoum DO. Early treatment with risperidone for subsyndromal delirium after on-pump cardiac surgery in the elderly a randomized trial. Anesthesiology. 2012;116:987–97.
    1. Alexopoulos GS, Streim J, Carpenter D, Docherty JP. Using antipsychotic agents in older patients. J Clin Psychiatry. 2004;65(Suppl. 2):5–99. discussion 100–2; quiz 3–4.
    1. Breitbart W, Gibson C, Tremblay A. The delirium experience: Delirium recall and delirium-related distress in hospitalized patients with cancer, their spouses/caregivers, and their nurses. Psychosomatics. 2002;43:183–94.
    1. MacLullich AM, Hall RJ. Who understands delirium? Age Ageing. 2011;40:412–4.
    1. Lu JH, Chan DK, Ong B, Shen Q, Reuten S, Ko A. Management and outcomes of delirium in a secured, co-located geriatric and psychogeriatric unit. J Am Geriatr Soc. 2009;57:1725–7.
    1. Fox MT, Persaud M, Maimets I, et al. Effectiveness of acute geriatric unit care using acute care for elders components: a systematic review and meta-analysis. J Am Geriatr Soc. 2012;60:2237–45.
    1. MacLullich AM, Beaglehole A, Hall RJ, Meagher DJ. Delirium and long-term cognitive impairment. Int Rev Psychiatry. 2009;21:30–42.
    1. Schofield I. A small exploratory study of the reaction of older people to an episode of delirium. J Adv Nurs. 1997;25:942–52.
    1. O'Malley G, Leonard M, Meagher D, O'Keeffe ST. The delirium experience: a review. J Psychosom Res. 2008;65:223–8.
    1. Partridge JS, Martin FC, Harari D, Dhesi JK. The delirium experience: what is the effect on patients, relatives and staff and what can be done to modify this? Int J Geriatr Psychiatry. 2012
    1. Rudolph JL, Boustani M, Kamholz B, Shaughnessey M, Shay K. Delirium: a strategic plan to bring an ancient disease into the 21st century. J Am Geriatr Soc. 2011;59(2):S237–40.
    1. Davis DH, Kreisel SH, Terrera GM, et al. The epidemiology of delirium: challenges and opportunities for population studies. Am J Geriatr Psychiatry. 2013 [Epub ahead of print]

Source: PubMed

スポンサーと協力者

医学的状態

薬物療法

3
購読する